Transasia Bio-Medicals has set up a state-of-the-art medical devices manufacturing plant at the Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, with an investment of Rs 30 crore.

The plant was formally inaugurated on 7 April 2021. Operations will start immediately at this new plant with product rollouts expected in early September 2021.

The largest-of-its-kind facility in Asia spread over 35,000 sq ft will manufacture ErbaLisa Covid-19 IgG ELISA test kits, RT-PCR kits and rapid test kits for India and other emerging markets. This is the fifth manufacturing facility for the Mumbai-based company along with plants in Baddi, Daman, Sikkim and Mumbai.

The facility, with an annual capacity of two million Molecular and Serology test kits, has face-recognition system, cold room, storage area, clean rooms of BSL-II/BSL-III grade, large lyophilizers, protein purification equipment, advanced QC equipment and automated machines.

It has the capacity to produce six lakh Elisa-based antibody detection test kits per day besides RT-PCR and rapid test kits.